Noncanonical Control of Vasopressin Receptor Type 2 Signaling by Retromer and Arrestin
Overview
Authors
Affiliations
The vasopressin type 2 receptor (V2R) is a critical G protein-coupled receptor (GPCR) for vertebrate physiology, including the balance of water and sodium ions. It is unclear how its two native hormones, vasopressin (VP) and oxytocin (OT), both stimulate the same cAMP/PKA pathway yet produce divergent antinatriuretic and antidiuretic effects that are either strong (VP) or weak (OT). Here, we present a new mechanism that differentiates the action of VP and OT on V2R signaling. We found that vasopressin, as opposed to OT, continued to generate cAMP and promote PKA activation for prolonged periods after ligand washout and receptor internalization in endosomes. Contrary to the classical model of arrestin-mediated GPCR desensitization, arrestins bind the VP-V2R complex yet extend rather than shorten the generation of cAMP. Signaling is instead turned off by the endosomal retromer complex. We propose that this mechanism explains how VP sustains water and Na(+) transport in renal collecting duct cells. Together with recent work on the parathyroid hormone receptor, these data support the existence of a novel "noncanonical" regulatory pathway for GPCR activation and response termination, via the sequential action of β-arrestin and the retromer complex.
Endosomal chemokine receptor signalosomes regulate central mechanisms underlying cell migration.
Hahn H, Daly C, Little 4th J, Perry-Hauser N, Flores-Espinoza E, Inoue A Elife. 2025; 13.
PMID: 39992711 PMC: 11850004. DOI: 10.7554/eLife.99373.
Genetic variants of accessory proteins and G proteins in human genetic disease.
Thompson M, Chidiac P, Jose P, Hauser A, Gorvin C Crit Rev Clin Lab Sci. 2025; 62(2):113-134.
PMID: 39743506 PMC: 11854058. DOI: 10.1080/10408363.2024.2431853.
Opioid receptors reveal a discrete cellular mechanism of endosomal G protein activation.
Fisher N, Von Zastrow M bioRxiv. 2024; .
PMID: 39416059 PMC: 11482822. DOI: 10.1101/2024.10.07.617095.
Subcellular activation of β-adrenergic receptors using a spatially restricted antagonist.
Liccardo F, Morstein J, Lin T, Pampel J, Lang D, Shokat K Proc Natl Acad Sci U S A. 2024; 121(40):e2404243121.
PMID: 39331410 PMC: 11459184. DOI: 10.1073/pnas.2404243121.
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors.
Toth A, Turu G, Hunyady L Nat Rev Nephrol. 2024; 20(11):722-741.
PMID: 39039165 DOI: 10.1038/s41581-024-00869-3.